Bennett Associates Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963K Buy
803
+137
+21% +$140K 0.6% 23
2026
Q1
$613K Buy
666
+224
+51% +$227K 0.41% 27
2025
Q4
$475K Buy
442
+133
+43% +$127K 0.33% 32
2025
Q3
$236K Buy
+309
New +$230K 0.17% 45

Other funds holding LLY

Bennett Associates Wealth Management's LLY Position: Q2 2026 in Review

Bennett Associates Wealth Management increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $140K and bringing the position to 803 shares worth $963K. The position accounts for 0.6% of the portfolio, ranked #23.

Bennett Associates Wealth Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bennett Associates Wealth Management held 803 shares of Eli Lilly worth $963K as of Q2 2026.
  • Bennett Associates Wealth Management bought 137 Eli Lilly shares in Q2 2026, an estimated $140K.
  • Eli Lilly made up 0.6% of Bennett Associates Wealth Management's portfolio in Q2 2026, its #23 holding.
  • Bennett Associates Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bennett Associates Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.